Shandong New Time Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is LASMIDITAN HEMISUCCINATE, with a corresponding US DMF Number 41900.
Remarkably, this DMF maintains an Active status since its submission on May 19, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 19, 2025, and payment made on July 02, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II